BETs abet Tam-R in ER-positive breast cancer

Prasanna G. Alluri, Irfan A. Asangani, Arul M. Chinnaiyan

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Epigenetic modifications such as histone acetylation play a central role in the transcriptional regulation of many oncogenic drivers. Accumulating evidence suggests that pharmacological modulation of certain key epigenetic reader proteins such as BRD2/3/4 may serve as an attractive strategy for treatment of many cancers, including tamoxifen-resistant breast cancer.

Original languageEnglish (US)
Pages (from-to)899-900
Number of pages2
JournalCell Research
Issue number8
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'BETs abet Tam-R in ER-positive breast cancer'. Together they form a unique fingerprint.

Cite this